Primary Cell Experiments with TG101348, a JAK2-Selective Inhibitor, in the Presence of Myeloproliferative Disorder-Associated JAK2V617F, MPLW515L/K, and JAK2 Exon 12 Mutations.
暂无分享,去创建一个
G. Noronha | H. Kantarjian | J. Cortes | S. Verstovsek | D. Gilliland | R. Mesa | A. Tefferi | J. Hood | R. Soll | C. Jamieson | T. Lasho | A. Pardanani | C. Finke